Other

Artis Ventures is a venture capital firm focused on investments at the convergence of frontier technologies and medicine. They invest in data-driven life sciences companies creating scalable medical technologies with broad healthcare applications. Their focus is on creating global impact through engineering-first approaches and flexible investment strategies.

Crosscut is a venture capital firm in Los Angeles investing in early-stage frontier technologies, both hardware and software. They partner with founders building solutions for various sectors, including energy transition, decarbonization, and advanced manufacturing, aiming to solve society's pressing problems.

Dreamers VC is a Los Angeles-based venture fund investing in early-stage companies. They focus on supporting innovative companies imagining more efficient and inclusive futures, leveraging a global network to connect founders with resources and opportunities.

Honeywell Ventures invests in companies and funds that align with its commercial interests.

Inovo is a seed-stage venture capital firm focused on startups in the CEE region and its diaspora. They invest in ambitious founders with a vision for companies exceeding $100M in revenue. Inovo's investment ticket size ranges from €0.5m to €4m.

Kapor Capital is an Oakland-based venture capital firm that invests in early-stage tech-enabled startups.

Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends. They partner with visionary founders to navigate the changing landscape of global business, providing high conviction support from Seed to Series F and beyond.

Sanofi Ventures is the corporate venture capital arm of Sanofi. They invest in top-tier biotech and digital health companies focusing on improving patient care and transforming healthcare. Their investments span from Seed to Series B and beyond, offering portfolio companies access to Sanofi's expertise.

Scout Ventures is a seed-stage venture capital firm focused on creating asymmetric, outsized returns by investing in cutting-edge early-stage technology that supports the frontiers of Western technology. Their seasoned team invests in dual-use technologies with both private and public sector applications, leveraging non-dilutive capital via defense and national lab networks.